The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
about
The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@ast
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@en
type
label
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@ast
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@en
prefLabel
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@ast
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@en
P2860
P356
P1476
The role of phosphodiesterase ...... benign prostatic hyperplasia.
@en
P2093
Mehmet Umul
Tekin Ahmet Serel
P2860
P304
P356
10.5152/TUD.2013.064
P577
2013-12-01T00:00:00Z